Condition: Crohn Disease (CD) · Sponsor: Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
Efficacy of Mirikizumab to achieve transmural healing in patients with Crohn's Disease
This description comes directly from the study's public registry record.
Julie MUSSOT · +33 6 27 49 29 10 · jmussot@getaid.org
Noemie DA COSTA · +33 9 72 57 61 60 · ndacosta@getaid.org
Always discuss trial participation with your own doctor first.
| CHU de Brest - Hôpital de la Cavale Blanche | Brest, France | Not Yet Recruiting |
| CHU de Clermont Ferrand - Hôpital d'Estaing | Clermont-Ferrand, France | Recruiting |
| CHU de Nîmes Carémeau | Nîmes, France | Not Yet Recruiting |
| Institut Mutualiste Monsouris | Paris, France | Not Yet Recruiting |
| CHU de Toulouse - Hôpital Rangueil | Toulouse, France | Not Yet Recruiting |
| CH de Valence | Valence, France | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07292012